Trials / Completed
CompletedNCT02039635
Korean Red Ginseng in Treating Patients With Fatigue Caused by Chemotherapy for Colorectal Cancer
A Study of Korean Red Ginseng for Evaluation of Improvement of Cancer-related Fatigue in Patients With Colorectal Cancer With Chemotherapy: A Randomized, Double-blind, Placebo-Controlled, Parallel, Multicenter Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 438 (actual)
- Sponsor
- Korea Ginseng Corporation · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Korean Red Ginseng may improve fatigue in healthy subject. It is not yet known whether Korean Red Ginseng is effective compared with a placebo in chemotherapy. The purpose of this study is to determine whether Korean Red Ginseng is effective in the treatment of the fatigue from colorectal cancer with chemotherapy.(modified FOLFOX-6)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Korean Red Ginseng | Given Orally |
| DIETARY_SUPPLEMENT | Placebo | Given Orally |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2016-08-01
- Completion
- 2017-03-01
- First posted
- 2014-01-17
- Last updated
- 2017-08-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02039635. Inclusion in this directory is not an endorsement.